ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO497

Outcome of Central Venoplasty and AVFistuloplasty in a Tertiary Care Centre in Eastern India

Session Information

  • Dialysis: Vascular Access
    November 03, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 803 Dialysis: Vascular Access


  • Sadhukhan, Sourav, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India
  • Pal, Atanu, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India
  • Datta, Aniruddha, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India

Access crisis is the Achilles heel of dialysis in ESRD patients. Central vein stenosis and stenosis in mature AVfistulas are common and negatively impact the quality of hemodialysis. Here we report the outcome of central venoplasty and fistuloplasty in our centre.


This was an retrospective observational study. Study period january21 to april22. Minimum follow up was 6 months.
Central venoplasty was preceded with venography. Right/left common femoral, internal jugular/venous limb of fistula were used as access, followed by gradual balloon dilatation and stent placement if required.
For fistuloplasty, arterial/venous limb was used as access, followed by balloon dilatation.


Total 38 primary and 5 secondary venoplasty performed.
42.1% patients had tunneled catheter,52.6% had AVF and 5.3% had temporary catheter.73.7%patients had access failure,26.3%- upper limb swelling.73.7% had CRBSI episodes>3. Mean duration to develop CVS-34.5m(SD-13.6m).
32(84.2%) were successful and 15.8% failed.Restenosis developed in 7(18.4%).Mean duration to develop restenosis-105.3d(SD-53.6d).
21 patients undergone Fistuloplasty. Mean patency of AVF -1.03Yr. perianastomotic stenosis -71.4% outflow stenosis -19.04%, inflow stenosis-9.52%.
Fistuloplasty was successful in 85.7% cases. Mean fistula flow volume-110.47ml/min(SD-79ml/min)(pre) 438ml/min(SD-244.9 ml/min)(post).
4 cases developed restenosis.
complications-minor bleeding-6 cases, venous rupture in 2 and brachial artery pseudoaneurysm in 1 case.


This outcome analysis suggests that central venoplasty and fistuloplasty have very good outcome in the management of access issues in ESRD patients, but cost and restenosis are the main limiting factors.

Types of AVF